These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7899365)

  • 21. Resistance to activated protein C in women using oral contraceptives.
    Spannagl M; Dick A; Assmann A; Heinemann L; Schramm W
    Semin Thromb Hemost; 1998; 24(5):423-30. PubMed ID: 9834008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Resistance to activated protein C. A common genetic risk factor in venous thrombosis].
    Berntorp E; Svensson P; Zöller B; Lethagen S; Dahlbäck B
    Lakartidningen; 1995 Sep; 92(39):3587-90. PubMed ID: 7564599
    [No Abstract]   [Full Text] [Related]  

  • 23. Thrombotic risk factors and oral contraception.
    Bokarewa MI; Falk G; Sten-Linder M; Egberg N; Blombäck M; Bremme K
    J Lab Clin Med; 1995 Sep; 126(3):294-8. PubMed ID: 7665978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
    Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
    J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age- and sex-specific incidence, risk, and latency period of a perioperative acute thromboembolism syndrome (PATS).
    Kikura M; Takada T; Sato S
    Thromb Haemost; 2004 Apr; 91(4):725-32. PubMed ID: 15045134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease.
    Mader R; Ziv M; Adawi M; Mader R; Lavi I
    J Rheumatol; 1999 Nov; 26(11):2404-8. PubMed ID: 10555901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of thrombophilia based on coagulation and genetic studies].
    Bałszan-Kowalska I
    Ann Acad Med Stetin; 2002; 48():179-93. PubMed ID: 14601477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited.
    Legnani C; Preda L; Palareti G; Lunghi B; Rossi E; Coccheri S
    Haematologica; 2002 Feb; 87(2):182-8. PubMed ID: 11836169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The clinical importance of protein C and S deficiency for surgical patients].
    Rabl H; Fruhwirth H
    Langenbecks Arch Chir; 1992; 377(2):75-80. PubMed ID: 1533892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ambulatory venous thromboembolitic disease. Clinical, etiological and evolutive data].
    Bory M; Yvorra S; Desfossez L; Panagides D; Bonnet JL; Massiani PF
    Presse Med; 1994 May; 23(18):839-44. PubMed ID: 7937604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden.
    Weitz IC; Israel VK; Liebman HA
    Cancer; 1997 May; 79(10):2024-7. PubMed ID: 9149031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboembolic complications after spinal surgery in trauma patients.
    Platzer P; Thalhammer G; Jaindl M; Obradovic A; Benesch T; Vecsei V; Gaebler C
    Acta Orthop; 2006 Oct; 77(5):755-60. PubMed ID: 17068706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of resistance to APC in young patients with retinal vein occlusion.
    Kuhli C; Hattenbach LO; Scharrer I; Koch F; Ohrloff C
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):163-8. PubMed ID: 11935272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. The OPTIMEV study.
    Galanaud JP; Genty C; Sevestre MA; Brisot D; Lausecker M; Gillet JL; Rolland C; Righini M; Leftheriotis G; Bosson JL; Quere I;
    Thromb Haemost; 2011 Jan; 105(1):31-9. PubMed ID: 20886192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutation.
    Manten B; Westendorp RG; Koster T; Reitsma PH; Rosendaal FR
    Thromb Haemost; 1996 Oct; 76(4):510-3. PubMed ID: 8902987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laparoscopic procedures as a risk factor of deep venous thrombosis, superficial ascending thrombophlebitis and pulmonary embolism--case report and review of the literature.
    Holzheimer RG
    Eur J Med Res; 2004 Sep; 9(9):417-22. PubMed ID: 15546806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Superficial venous thrombosis of the lower limbs: prospective analysis in 100 patients].
    Gillet JL; Perrin M; Cayman R
    J Mal Vasc; 2001 Feb; 26(1):16-22. PubMed ID: 11240525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study.
    Pabinger I; Kyrle PA; Heistinger M; Eichinger S; Wittmann E; Lechner K
    Thromb Haemost; 1994 Apr; 71(4):441-5. PubMed ID: 8052960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherited resistance to activated protein C, a major basis of venous thrombosis, is caused by deficient anticoagulant cofactor function of factor V.
    Dahlbäck B
    Haematologica; 1995; 80(2 Suppl):102-13. PubMed ID: 7628762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.